Medmen: Canaccord Reiterates $0 Price Target, Sell Rating
On December 7th, Medmen Enterprises’ (CSE: MMEN) reported first-quarter fiscal 2021 financial results. Medmen reported revenues of $35.6 million, up
Read more
MedMen Enterprises
Canaccord Drops Medmen Price Target To $0.00, Reiterates Sell Rating
After Medmen Enterprises’ (CSE: MMEN) fourth-quarter results dropped after hours on October 15th, Canaccord downgraded Medmen’s 12-month price target to
Read more
MedMen Sees Founders Sell Shares Continuously Through July
Evidently, now is a bad time to hold equity in Medmen Enterprises (CSE: MMEN) – that is, if you’re one
Read more
Medmen Modifies Debt Facilities, Lease Terms To Improve Near Term Liquidity
MedMen Enterprises (CSE: MMEN) this morning announced that it has amended several of its outstanding credit facilities as a means
Read more
Medmen Sees At Least Two LA Dispensaries Looted In Riots
It appears that the ongoing riots throughout the USA have not been kind to a certain dispensary operator. Video emerged
Read more
Rough Week In Cannabis Sector Capped With Gut Punch From Ontario
This first week of April has been the never-ending week for the cannabis industry that has been continuously gut punched
Read more
Medmen Cancels Guidance, Amends GGP Facility, Names Interim Officers
Medmen Enterprises (CSE: MMEN) this morning released a corporate update that covered a range of topics, including additional funding from
Read more
MedMen Posts Flat Revenues, Loss of $40.6 Million For Second Quarter
Medmen Enterprises (CSE: MMEN) filed their second quarter 2020 financials this evening after the bell, revealing revenues of $44.0 million
Read more
MedMen Settles $3.3 Million In Vendor Debt With Share Issuances
The pace of dilution at Medmen Enterprises (CSE: MMEN) appears to be increasing as the firm continues to issue Class
Read more
Adam Bierman Resigns As CEO of Medmen Enterprises
It appears to be the end of an era. Medmen Enterprises (CSE: MMEN) this morning announced that co-founder and current
Read more